1	Aspirin	aspirin	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	factor-kappa	factor-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	mobilization	mobilization	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	monocyte	monocyte	_	_	_	_	_	_	_
9	adhesion	adhesion	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	stimulated	stimulate	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	endothelial	endothelial	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	induction	induction	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	vascular	vascular	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	adhesion	adhesion	_	_	_	_	_	_	_
9	molecule-1	molecule-1	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	VCAM-1	vcam-1	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	E-selectin	E-selectin	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	tumor	tumor	_	_	_	_	_	_	_
17	necrosis	necrosis	_	_	_	_	_	_	_
18	factor-alpha	factor-alpha	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TNF	TNF	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	mediated	mediate	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	mobilization	mobilization	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	transcription	transcription	_	_	_	_	_	_	_
29	factor	factor	_	_	_	_	_	_	_
30	nuclear	nuclear	_	_	_	_	_	_	_
31	factor-kappa	factor-kappa	_	_	_	_	_	_	_
32	B	B	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	NF-kappa	NF-kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	salicylates	salicylate	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	been	be	_	_	_	_	_	_	_
5	reported	report	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	inhibit	inhibit	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	preventing	prevent	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	degradation	degradation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	its	its	_	_	_	_	_	_	_
17	inhibitor	inhibitor	_	_	_	_	_	_	_
18	I	i	_	_	_	_	_	_	_
19	kappa	kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	we	we	_	_	_	_	_	_	_
23	studied	study	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	potential	potential	_	_	_	_	_	_	_
26	inhibition	inhibition	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	this	this	_	_	_	_	_	_	_
29	pathway	pathway	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	acetylsalicylate	acetylsalicylate	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	aspirin	aspirin	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	human	human	_	_	_	_	_	_	_
37	umbilical	umbilical	_	_	_	_	_	_	_
38	vein	vein	_	_	_	_	_	_	_
39	endothelial	endothelial	_	_	_	_	_	_	_
40	cells	cell	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	HUVECs	HUVEC	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	RESULTS	results	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	Gel-shift	gel-shift	_	_	_	_	_	_	_
6	analyses	analysis	_	_	_	_	_	_	_
7	demonstrated	demonstrate	_	_	_	_	_	_	_
8	dose-dependent	dose-dependent	_	_	_	_	_	_	_
9	inhibition	inhibition	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	TNF-induced	tnf-induced	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	mobilization	mobilization	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	aspirin	aspirin	_	_	_	_	_	_	_
17	at	at	_	_	_	_	_	_	_
18	concentrations	concentration	_	_	_	_	_	_	_
19	ranging	range	_	_	_	_	_	_	_
20	from	from	_	_	_	_	_	_	_
21	1	1	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	10	10	_	_	_	_	_	_	_
24	mmol/L.	mmol/l.	_	_	_	_	_	_	_
25	Induction	induction	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	VCAM-1	VCAM-1	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	E-selectin	E-selectin	_	_	_	_	_	_	_
30	surface	surface	_	_	_	_	_	_	_
31	expression	expression	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	TNF	TNF	_	_	_	_	_	_	_
34	was	be	_	_	_	_	_	_	_
35	dose-dependently	dose-dependently	_	_	_	_	_	_	_
36	reduced	reduce	_	_	_	_	_	_	_
37	by	by	_	_	_	_	_	_	_
38	aspirin	aspirin	_	_	_	_	_	_	_
39	over	over	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	same	same	_	_	_	_	_	_	_
42	range	range	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	while	while	_	_	_	_	_	_	_
45	induction	induction	_	_	_	_	_	_	_
46	of	of	_	_	_	_	_	_	_
47	intercellular	intercellular	_	_	_	_	_	_	_
48	adhesion	adhesion	_	_	_	_	_	_	_
49	molecule-1	molecule-1	_	_	_	_	_	_	_
50	(	(	_	_	_	_	_	_	_
51	ICAM-1	icam-1	_	_	_	_	_	_	_
52	)	)	_	_	_	_	_	_	_
53	was	be	_	_	_	_	_	_	_
54	hardly	hardly	_	_	_	_	_	_	_
55	affected	affect	_	_	_	_	_	_	_
56	.	.	_	_	_	_	_	_	_

1	Aspirin	aspirin	_	_	_	_	_	_	_
2	appeared	appear	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	prevent	prevent	_	_	_	_	_	_	_
5	VCAM-1	vcam-1	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	since	since	_	_	_	_	_	_	_
9	it	it	_	_	_	_	_	_	_
10	dose-dependently	dose-dependently	_	_	_	_	_	_	_
11	inhibited	inhibit	_	_	_	_	_	_	_
12	induction	induction	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	VCAM-1	VCAM-1	_	_	_	_	_	_	_
15	mRNA	mRNA	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	TNF	TNF	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	functional	functional	_	_	_	_	_	_	_
4	consequence	consequence	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	adhesion	adhesion	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	U937	u937	_	_	_	_	_	_	_
9	monocytes	monocyte	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	TNF-stimulated	tnf-stimulated	_	_	_	_	_	_	_
12	HUVECs	huvec	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	markedly	markedly	_	_	_	_	_	_	_
15	reduced	reduce	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	aspirin	aspirin	_	_	_	_	_	_	_
18	due	due	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	suppression	suppression	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	VCAM-1	VCAM-1	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	E-selectin	E-selectin	_	_	_	_	_	_	_
25	upregulation	upregulation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	aspirin	aspirin	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	not	not	_	_	_	_	_	_	_
7	related	related	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	inhibition	inhibition	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	cyclooxygenase	cyclooxygenase	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	since	since	_	_	_	_	_	_	_
16	indomethacin	indomethacin	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	ineffective	ineffective	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Our	our	_	_	_	_	_	_	_
4	data	datum	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	aspirin	aspirin	_	_	_	_	_	_	_
8	inhibits	inhibit	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	mobilization	mobilization	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	induction	induction	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	VCAM-1	VCAM-1	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	E-selectin	E-selectin	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	subsequent	subsequent	_	_	_	_	_	_	_
21	monocyte	monocyte	_	_	_	_	_	_	_
22	adhesion	adhesion	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	endothelial	endothelial	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	stimulated	stimulate	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	TNF	TNF	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	thereby	thereby	_	_	_	_	_	_	_
31	providing	provide	_	_	_	_	_	_	_
32	an	an	_	_	_	_	_	_	_
33	additional	additional	_	_	_	_	_	_	_
34	mechanism	mechanism	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	therapeutic	therapeutic	_	_	_	_	_	_	_
37	effects	effect	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	aspirin	aspirin	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

